Header Logo

Christopher Seder

Concepts (363)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
35
2022
553
9.130
Why?
Carcinoma, Non-Small-Cell Lung
15
2021
244
5.480
Why?
Pneumonectomy
20
2022
77
5.320
Why?
Thoracic Surgery
14
2022
27
4.940
Why?
Esophageal Neoplasms
8
2022
54
3.730
Why?
Databases, Factual
13
2021
358
2.310
Why?
Societies, Medical
11
2020
154
2.110
Why?
Adenocarcinoma
8
2018
147
2.100
Why?
Thoracic Surgical Procedures
5
2019
9
1.810
Why?
Neoplasm Staging
13
2021
371
1.730
Why?
Humans
74
2023
28560
1.500
Why?
Thoracic Wall
3
2016
12
1.410
Why?
Postoperative Complications
8
2022
934
1.390
Why?
Quality Improvement
4
2019
161
1.330
Why?
Thoracic Surgery, Video-Assisted
7
2021
22
1.160
Why?
Neoplasm Recurrence, Local
3
2017
206
1.120
Why?
Biomarkers, Tumor
7
2022
202
1.110
Why?
Lung
5
2022
170
1.050
Why?
Aged
33
2021
9334
1.030
Why?
Neoplasms, Multiple Primary
2
2015
42
0.980
Why?
Female
39
2022
15818
0.920
Why?
Male
41
2022
15400
0.890
Why?
Cardiac Surgical Procedures
2
2016
45
0.870
Why?
Laparoscopy
3
2022
198
0.830
Why?
Colonic Neoplasms
3
2017
61
0.830
Why?
Biology
1
2022
8
0.820
Why?
Robotics
2
2013
25
0.810
Why?
Phosphoproteins
1
2022
28
0.810
Why?
Carcinoma, Adenoid Cystic
1
2022
3
0.790
Why?
Middle Aged
28
2022
9316
0.770
Why?
Registries
2
2021
188
0.750
Why?
Retrospective Studies
18
2022
3612
0.730
Why?
Robotic Surgical Procedures
1
2021
34
0.720
Why?
Advisory Committees
2
2018
25
0.720
Why?
Surgical Oncology
1
2020
6
0.720
Why?
Lymphadenopathy
1
2020
1
0.690
Why?
Checklist
1
2020
40
0.690
Why?
Prognosis
9
2022
826
0.680
Why?
Combined Modality Therapy
5
2020
307
0.670
Why?
Gases
1
2019
5
0.660
Why?
Intubation, Gastrointestinal
2
2010
12
0.650
Why?
Hate
1
2019
2
0.650
Why?
Chest Tubes
1
2019
3
0.650
Why?
Inhibin-beta Subunits
2
2009
2
0.650
Why?
Thoracotomy
3
2021
29
0.650
Why?
Carcinoma, Squamous Cell
4
2019
177
0.650
Why?
Clostridium Infections
2
2009
21
0.630
Why?
Catheter Ablation
1
2020
72
0.630
Why?
Enteral Nutrition
2
2010
65
0.620
Why?
Aged, 80 and over
15
2018
4894
0.610
Why?
Diaphragm
1
2018
8
0.600
Why?
Mucous Membrane
1
2018
29
0.590
Why?
Heart Diseases
2
2016
70
0.590
Why?
Foreign-Body Migration
1
2018
19
0.590
Why?
Scoliosis
1
2018
33
0.570
Why?
Internationality
1
2017
25
0.570
Why?
Databases as Topic
1
2017
15
0.560
Why?
Prosthesis Failure
2
2018
539
0.560
Why?
Risk Assessment
5
2019
677
0.560
Why?
Quality Assurance, Health Care
1
2017
38
0.550
Why?
Benchmarking
1
2017
38
0.550
Why?
Adult
16
2018
8168
0.550
Why?
Ribs
1
2016
15
0.520
Why?
Metformin
1
2016
20
0.510
Why?
Cardiology
1
2016
57
0.510
Why?
Hypoglycemic Agents
1
2016
40
0.510
Why?
Pulmonary Blastoma
1
2015
4
0.510
Why?
Mediastinal Neoplasms
1
2015
11
0.510
Why?
Nurse Practitioners
1
2017
109
0.500
Why?
Testicular Neoplasms
1
2015
19
0.500
Why?
Neoplasm Invasiveness
4
2018
89
0.500
Why?
Academic Medical Centers
1
2016
137
0.500
Why?
United States
9
2021
2197
0.490
Why?
Solitary Pulmonary Nodule
1
2015
15
0.490
Why?
Lung Diseases, Fungal
1
2015
10
0.480
Why?
Mucormycosis
1
2015
9
0.480
Why?
Early Medical Intervention
1
2015
15
0.480
Why?
Quality of Health Care
1
2016
126
0.470
Why?
Treatment Outcome
13
2021
3620
0.460
Why?
Survival Rate
7
2021
356
0.460
Why?
Surgical Mesh
1
2014
26
0.450
Why?
Risk Adjustment
3
2020
11
0.450
Why?
Manubrium
1
2014
2
0.450
Why?
Replantation
1
2014
10
0.450
Why?
Clavicle
1
2014
14
0.450
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
242
0.450
Why?
Herniorrhaphy
1
2014
38
0.440
Why?
Practice Guidelines as Topic
1
2016
320
0.440
Why?
Diabetes Mellitus, Type 2
1
2016
191
0.430
Why?
Esophagectomy
3
2022
24
0.420
Why?
Mitral Valve Annuloplasty
1
2012
1
0.410
Why?
Tricuspid Valve Prolapse
1
2012
2
0.410
Why?
Prostheses and Implants
1
2014
163
0.400
Why?
Heart Valve Prosthesis Implantation
1
2012
28
0.400
Why?
Breast Neoplasms
2
2017
409
0.400
Why?
Surgery, Computer-Assisted
1
2012
53
0.390
Why?
Cell Line, Tumor
4
2022
249
0.380
Why?
Survival Analysis
3
2018
267
0.360
Why?
Spinal Fusion
1
2018
473
0.360
Why?
Tomography, X-Ray Computed
6
2018
772
0.360
Why?
Simulation Training
2
2021
38
0.350
Why?
Myxoma
1
2010
4
0.350
Why?
Mitral Valve
1
2010
10
0.350
Why?
Heart Neoplasms
1
2010
13
0.350
Why?
Neoadjuvant Therapy
3
2022
66
0.340
Why?
Energy Intake
1
2010
82
0.330
Why?
Aneurysm, Infected
1
2009
1
0.330
Why?
Clostridium septicum
1
2009
1
0.330
Why?
Aortitis
1
2009
2
0.330
Why?
Gene Expression Regulation, Neoplastic
2
2009
112
0.320
Why?
Embolism
1
2009
3
0.320
Why?
Embolectomy
1
2009
4
0.320
Why?
Blood Component Transfusion
1
2009
4
0.320
Why?
Mesenteric Vascular Occlusion
1
2009
4
0.320
Why?
Jehovah's Witnesses
1
2009
3
0.320
Why?
Treatment Refusal
1
2009
11
0.320
Why?
Aortic Aneurysm
1
2009
14
0.320
Why?
Ischemia
1
2009
23
0.320
Why?
Enterocolitis, Pseudomembranous
1
2009
11
0.320
Why?
Length of Stay
4
2016
328
0.320
Why?
Blood Vessel Prosthesis Implantation
3
2018
21
0.320
Why?
Religion and Medicine
1
2009
24
0.320
Why?
Intraoperative Complications
1
2009
67
0.310
Why?
Bronchoscopy
3
2019
34
0.310
Why?
Internship and Residency
3
2018
219
0.310
Why?
Epigenesis, Genetic
1
2009
86
0.300
Why?
Surgeons
2
2020
89
0.300
Why?
Risk Factors
4
2022
2412
0.300
Why?
Hospital Costs
1
2008
64
0.300
Why?
Education, Medical, Graduate
2
2020
77
0.290
Why?
Critical Care
1
2010
199
0.290
Why?
Sarcoma
2
2021
144
0.280
Why?
Disease-Free Survival
2
2017
177
0.260
Why?
Trachea
2
2022
49
0.260
Why?
Follow-Up Studies
5
2021
1863
0.260
Why?
Intensive Care Units
1
2008
299
0.260
Why?
Clinical Competence
3
2020
249
0.250
Why?
Early Detection of Cancer
4
2022
104
0.240
Why?
Neovascularization, Pathologic
2
2015
36
0.240
Why?
Biomarkers
2
2017
601
0.230
Why?
Surgical Flaps
2
2015
51
0.230
Why?
Chemoradiotherapy
2
2015
61
0.220
Why?
Embolism, Air
1
2023
10
0.220
Why?
Consensus
2
2021
98
0.220
Why?
Bronchi
2
2015
12
0.210
Why?
Thymoma
2
2020
7
0.210
Why?
Blood Coagulation Disorders
1
2022
16
0.200
Why?
Thrombosis
1
2023
58
0.200
Why?
Thymus Neoplasms
2
2020
11
0.200
Why?
Computer Simulation
2
2021
205
0.200
Why?
Hemostatics
1
2022
13
0.200
Why?
Carbon Monoxide
1
2022
7
0.200
Why?
Lymph Nodes
2
2020
70
0.190
Why?
Intubation, Intratracheal
2
2016
99
0.190
Why?
Metastasectomy
1
2021
7
0.190
Why?
Programmed Cell Death 1 Receptor
1
2022
17
0.190
Why?
Cohort Studies
4
2018
1940
0.190
Why?
Multivariate Analysis
3
2017
331
0.190
Why?
Ventricular Dysfunction, Right
1
2021
11
0.180
Why?
Heart-Assist Devices
1
2021
18
0.180
Why?
Patient Discharge
1
2022
162
0.180
Why?
Incidence
2
2021
774
0.180
Why?
Mediastinal Cyst
1
2020
1
0.170
Why?
Mass Screening
2
2022
182
0.170
Why?
RNA, Messenger
3
2009
309
0.170
Why?
Carcinoma
2
2017
69
0.160
Why?
Smoking
1
2020
176
0.160
Why?
Small Cell Lung Carcinoma
1
2019
9
0.160
Why?
Ultrasonography, Interventional
1
2020
76
0.160
Why?
False Positive Reactions
1
2019
36
0.160
Why?
Insulin-Like Growth Factor I
2
2022
59
0.160
Why?
Drainage
1
2019
49
0.160
Why?
RNA, Small Interfering
2
2009
79
0.160
Why?
Sensitivity and Specificity
4
2018
519
0.160
Why?
Unnecessary Procedures
1
2019
30
0.160
Why?
Heart Failure
1
2021
179
0.160
Why?
Kaplan-Meier Estimate
2
2009
179
0.160
Why?
Thoracoscopy
3
2019
23
0.150
Why?
Obesity
1
2021
321
0.150
Why?
Aortic Aneurysm, Thoracic
1
2018
10
0.150
Why?
Randomized Controlled Trials as Topic
1
2020
329
0.150
Why?
Cell Proliferation
2
2009
178
0.150
Why?
Histocompatibility Antigens Class II
1
2018
6
0.150
Why?
HLA Antigens
1
2018
17
0.150
Why?
Hemoptysis
1
2018
7
0.150
Why?
Multiple Pulmonary Nodules
1
2018
12
0.150
Why?
Syndecan-1
1
2018
4
0.150
Why?
Histocompatibility Antigens Class I
1
2018
18
0.150
Why?
Immunohistochemistry
2
2009
364
0.150
Why?
Radiography, Thoracic
1
2018
28
0.150
Why?
Chest Pain
1
2018
19
0.150
Why?
Morbidity
2
2019
58
0.150
Why?
Immunoassay
1
2018
40
0.150
Why?
Diagnosis, Differential
2
2018
373
0.150
Why?
Nerve Growth Factors
1
2018
37
0.140
Why?
Tracheomalacia
1
2017
4
0.140
Why?
Tracheal Stenosis
1
2017
6
0.140
Why?
Silicones
1
2017
12
0.140
Why?
Bronchial Neoplasms
1
2017
5
0.140
Why?
Airway Obstruction
1
2017
20
0.140
Why?
Suture Techniques
1
2018
157
0.140
Why?
Lymphoma
1
2017
38
0.140
Why?
History, 21st Century
1
2016
24
0.140
Why?
History, 19th Century
1
2016
29
0.140
Why?
History, 20th Century
1
2016
47
0.130
Why?
Stents
1
2017
86
0.130
Why?
Diffusion of Innovation
1
2016
32
0.130
Why?
Melanoma
1
2017
60
0.130
Why?
Biopsy
1
2017
220
0.130
Why?
Pneumonia, Bacterial
1
2016
11
0.130
Why?
Pulmonary Diffusing Capacity
1
2016
9
0.130
Why?
Tracheostomy
1
2016
27
0.130
Why?
Europe
1
2016
66
0.130
Why?
Adolescent
1
2022
2319
0.130
Why?
Minimally Invasive Surgical Procedures
2
2010
318
0.130
Why?
Etoposide
1
2015
26
0.130
Why?
Ifosfamide
1
2015
14
0.130
Why?
Prospective Studies
1
2021
1807
0.130
Why?
Models, Statistical
1
2016
129
0.130
Why?
Cisplatin
1
2015
53
0.120
Why?
Thymus Gland
1
2015
11
0.120
Why?
Time Factors
1
2019
1501
0.120
Why?
Proportional Hazards Models
1
2016
352
0.120
Why?
Diabetes Mellitus
1
2016
137
0.120
Why?
Insulin-Like Growth Factor II
1
2014
10
0.120
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
10
0.120
Why?
Comorbidity
1
2016
501
0.110
Why?
Antineoplastic Agents
1
2016
190
0.110
Why?
Thoracic Cavity
1
2014
1
0.110
Why?
Thoracic Neoplasms
1
2014
9
0.110
Why?
Chicago
1
2016
939
0.110
Why?
Mediastinum
1
2013
7
0.110
Why?
Hernia, Hiatal
1
2013
14
0.110
Why?
Fatal Outcome
2
2011
57
0.100
Why?
Tricuspid Valve Insufficiency
1
2012
5
0.100
Why?
Histone Acetyltransferases
2
2009
3
0.100
Why?
Acetylation
2
2009
14
0.100
Why?
Histone Deacetylases
2
2009
11
0.100
Why?
Dyspnea
1
2012
42
0.100
Why?
Oligonucleotide Array Sequence Analysis
2
2009
57
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2009
139
0.100
Why?
Fistula
1
2011
3
0.090
Why?
Gastric Fistula
1
2011
5
0.090
Why?
Age Factors
2
2016
788
0.090
Why?
Anastomotic Leak
1
2011
7
0.090
Why?
Lung Transplantation
1
2011
13
0.090
Why?
Living Donors
1
2011
17
0.090
Why?
Continuous Positive Airway Pressure
1
2011
22
0.090
Why?
Tissue and Organ Procurement
1
2011
35
0.090
Why?
Postoperative Hemorrhage
1
2011
24
0.090
Why?
Graft Rejection
1
2011
71
0.090
Why?
Sutures
1
2011
52
0.090
Why?
Endoleak
1
2010
1
0.090
Why?
Aortic Aneurysm, Abdominal
1
2010
3
0.090
Why?
Chordae Tendineae
1
2010
1
0.090
Why?
Blood Pressure Determination
1
2010
16
0.090
Why?
Blood Vessel Prosthesis
1
2010
12
0.090
Why?
Monitoring, Intraoperative
1
2010
37
0.090
Why?
Surgical Tape
1
2010
3
0.090
Why?
Conscious Sedation
1
2010
6
0.090
Why?
Glasgow Coma Scale
1
2010
9
0.090
Why?
APACHE
1
2010
31
0.090
Why?
Equipment Failure
1
2010
39
0.090
Why?
Endovascular Procedures
1
2010
34
0.090
Why?
Gastric Bypass
1
2011
70
0.080
Why?
Heart Ventricles
1
2010
115
0.080
Why?
Activins
1
2009
1
0.080
Why?
Follistatin
1
2009
1
0.080
Why?
Mesenteric Artery, Superior
1
2009
3
0.080
Why?
Tissue Array Analysis
1
2009
7
0.080
Why?
Probability
1
2009
92
0.080
Why?
Iliac Artery
1
2009
5
0.080
Why?
Statistics, Nonparametric
1
2009
130
0.080
Why?
Aorta
1
2009
16
0.080
Why?
Multiple Organ Failure
1
2009
21
0.080
Why?
Blood Pressure
1
2010
208
0.080
Why?
Digestive System Surgical Procedures
1
2009
24
0.080
Why?
Histones
1
2009
28
0.080
Why?
Cattle
1
2009
128
0.080
Why?
Transfection
1
2009
122
0.080
Why?
Blotting, Western
1
2009
148
0.080
Why?
Histone Deacetylase Inhibitors
1
2008
8
0.080
Why?
Promoter Regions, Genetic
1
2009
99
0.080
Why?
Safety
1
2008
45
0.080
Why?
Debridement
1
2009
102
0.080
Why?
Glycoproteins
1
2008
47
0.080
Why?
Cost-Benefit Analysis
1
2008
134
0.080
Why?
Enzyme Inhibitors
1
2008
120
0.080
Why?
Acute Disease
1
2009
208
0.080
Why?
Anticoagulants
1
2009
90
0.080
Why?
Carrier Proteins
1
2008
106
0.070
Why?
Recurrence
1
2009
322
0.070
Why?
Autoantibodies
1
2008
80
0.070
Why?
Up-Regulation
1
2009
177
0.070
Why?
DNA Methylation
1
2009
165
0.070
Why?
Anti-Bacterial Agents
1
2009
376
0.060
Why?
Magnetic Resonance Imaging
1
2010
1194
0.060
Why?
Reproducibility of Results
2
2019
735
0.060
Why?
Iatrogenic Disease
1
2023
28
0.050
Why?
Thrombelastography
1
2022
5
0.050
Why?
Blood Coagulation Tests
1
2022
11
0.050
Why?
Hemostasis
1
2022
10
0.050
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2022
5
0.050
Why?
Hemorrhage
1
2022
81
0.050
Why?
Tumor Microenvironment
1
2022
16
0.050
Why?
Inflammation
1
2023
288
0.050
Why?
Predictive Value of Tests
2
2014
496
0.050
Why?
Animals
1
2009
3812
0.050
Why?
Equipment Design
2
2011
155
0.040
Why?
Young Adult
2
2017
2102
0.040
Why?
Mediastinoscopy
1
2019
7
0.040
Why?
Hemolysis
1
2018
5
0.040
Why?
North America
1
2018
43
0.040
Why?
Canada
1
2018
51
0.040
Why?
Magnetic Resonance Angiography
1
2018
31
0.040
Why?
Pneumonia
1
2019
77
0.040
Why?
Carcinoma, Embryonal
1
2017
3
0.040
Why?
Dilatation
1
2017
10
0.040
Why?
Tonsillar Neoplasms
1
2017
3
0.040
Why?
Leiomyosarcoma
1
2017
21
0.030
Why?
Carcinoma, Renal Cell
1
2017
48
0.030
Why?
Propensity Score
1
2016
36
0.030
Why?
Kidney Neoplasms
1
2017
79
0.030
Why?
Skin Neoplasms
1
2017
79
0.030
Why?
Neoplasm, Residual
1
2015
8
0.030
Why?
Practice Patterns, Physicians'
1
2016
122
0.030
Why?
Lymph Node Excision
1
2015
27
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2015
17
0.030
Why?
Radiotherapy Dosage
1
2015
117
0.030
Why?
Minnesota
1
2014
9
0.030
Why?
Sex Factors
1
2016
476
0.030
Why?
Area Under Curve
1
2014
62
0.030
Why?
Postoperative Period
1
2016
331
0.030
Why?
Analysis of Variance
1
2015
276
0.030
Why?
ROC Curve
1
2014
144
0.030
Why?
Illinois
1
2014
247
0.030
Why?
Patient Readmission
1
2015
133
0.030
Why?
Cytokines
1
2014
231
0.030
Why?
Algorithms
1
2014
380
0.020
Why?
Disease Progression
1
2014
722
0.020
Why?
Hematemesis
1
2011
2
0.020
Why?
Stomach Ulcer
1
2011
4
0.020
Why?
Esophageal Perforation
1
2011
8
0.020
Why?
Proton Pump Inhibitors
1
2011
14
0.020
Why?
Candidiasis
1
2011
22
0.020
Why?
Gastrointestinal Hemorrhage
1
2011
20
0.020
Why?
Pulmonary Gas Exchange
1
2011
7
0.020
Why?
Surgical Stapling
1
2011
5
0.020
Why?
Constriction, Pathologic
1
2011
33
0.020
Why?
Graft Survival
1
2011
102
0.020
Why?
Transducers, Pressure
1
2010
4
0.020
Why?
Aortography
1
2010
6
0.020
Why?
Respiration, Artificial
1
2011
114
0.020
Why?
Rupture
1
2010
114
0.020
Why?
Obesity, Morbid
1
2011
104
0.020
Why?
Hydroxamic Acids
1
2008
5
0.020
Why?
Adipokines
1
2008
7
0.020
Why?
Immunoenzyme Techniques
1
2008
32
0.020
Why?
Azacitidine
1
2008
10
0.020
Why?
Tumor Cells, Cultured
1
2008
120
0.020
Why?
Gene Expression Profiling
1
2008
139
0.020
Why?
Reoperation
1
2011
917
0.020
Why?
Case-Control Studies
1
2008
599
0.020
Why?
Seder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (363)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_